The Coconut Oil and Low-Carb Solution for Alzheimer's, Parkinson's, and Other Diseases

Mary T. Newport

Description

From the author of the best-seller Alzheimer's Disease; What if There Was a Cure?, Mary T. Newport, M.D.,now presents this guide of how to integrate diet in the treatment of neurodegenerative diseases.

Sujets

• Santé et bien-être
• Diététique
• Santé du quotidien
• Santé au quotidien
• Santé au quotidien
• Parkinson's disease
• Alzheimer's disease
• Dementia
• Diet
• Health
• Fitness
• Alzheimer
• Nutrition
• diététique

Informations

• Publié par: Turner Publishing Company
• Date de parution: 01 août 2015
• Nombre de lectures: 0
• EAN13: 9781681629490
• Langue: English
• Poids de l'ouvrage: 1 Mo

Extrait

The Coconut Oil Low-Carb Solution
For Alzheimer s, Parkinson s, and Other Diseases
A STEP-BY-STEP GUIDE TO USING DIET AND HIGH-ENERGY FOODS TO PROTECT AND NOURISH THE BRAIN
MARY T. NEWPORT, M.D.
The information contained in this book is based upon the research and personal and professional experiences of the author. It is not intended as a substitute for consulting with your physician or other healthcare provider. Any attempt to diagnose and treat an illness should be done under the direction of a healthcare professional.
The publisher does not advocate the use of any particular healthcare protocol but believes the information in this book should be available to the public. The publisher and author are not responsible for any adverse effects or consequences resulting from the use of the suggestions, preparations, or procedures discussed in this book. Should the reader have any questions concerning the appropriateness of any procedures or preparation mentioned, the author and the publisher strongly suggest consulting a professional healthcare advisor.
Basic Health Publications, Inc.
www.basichealthpub.com
Library of Congress Cataloging-in-Publication Data
Newport, Mary T.
The coconut oil and low-carb solution for Alzheimer s, Parkinson s, and other diseases / Mary T. Newport, M.D.
pages cm
Includes bibliographical references and index.
ISBN 978-1-59120-381-0 (Pbk.)
ISBN 978-1-68162-909-4 (Hardcover)
1. Alzheimer s disease-Diet therapy. 2. Coconut oil-Therapeutic use. 3. Fatty acids-Therapeutic use. I. Title.
RC523.N536 2015
616.8 310654--dc23
2015024162
Copyright 2015 Mary T. Newport, M.D.
All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the author.
Editor: Cheryl Hirsch Typesetting/Book design: Gary A. Rosenberg Text illustrations: Joanna Newport Cover photos: Kathryn O Malley Cover design: Kimberly Richey
Contents
Acknowledgments
Preface
Introduction
PART ONE

A Dietary Plan to Overcome Insulin Resistance
1. A Quick-Start Guide to Using Coconut and Medium-Chain Triglyceride (MCT) Oils
2. Go One Giant Step Further: A Low-Carb Diet
3. More About Coconut Oil with Questions and Answers
4. More About MCT Oil with Questions and Answers
5. Recipes: Cooking with Coconut and MCT Oils
PART TWO

Disorders That May Respond to Ketones with Caregiver Reports and Personal Accounts
6. An Analysis of Caregiver Reports for People with Dementias and Other Memory Impairment
7. Alzheimer s Disease
8. Non-Alzheimer s Dementias
9. Parkinson s Disease
10. Amyotrophic Lateral Sclerosis
11. Multiple Sclerosis
PART THREE

The Science
12. Diabetes of the Brain
13. Ketones as an Alternative Fuel for the Brain
Afterword: Help for the Caregivers Is Long Overdue
Appendices
APPENDIX 1 Fifty Conditions That May Respond to Raising Ketones
APPENDIX 2 Possible Causes and Contributors to Alzheimer s Disease
APPENDIX 3 The Seven Stages of Alzheimer s Disease
Resources
References and Related Articles
Index
About the Author
There s no place like home.
-D OROTHY , T HE W IZARD OF O Z

This book is dedicated to Steve, the love of my life, who made it possible for me to be both mother and doctor. He may ultimately lose his battle with Alzheimer s, but we are fighting it together with everything we have. Hopefully, the path we have taken in our battle will make it possible for many others to win.
This book is also dedicated to our helpers who have endured the unimaginable-true friends and true caregivers who fight this battle with us and make it possible to keep Steve at home with me.
Acknowledgments
Like my previous book, this one would not exist were it not for the dedication and persistence of Richard L. Veech, M.D., Ph.D., who, over many years, has pursued what ketones do and how they might be used as an alternative fuel to make lives better for people with Alzheimer s, Parkinson s, amyotrophic lateral sclerosis, multiple sclerosis, and a myriad of other conditions. There are not enough words to express how sincerely grateful we are for what he has done to give our family extra quality years with my husband and our children s father, Steve. I also wish to thank M. Todd King, Yoshira Kashiwaya, M.D., and the many others who have worked alongside Dr. Veech in the pursuit of knowledge about ketones.
I also wish to acknowledge Theodore B. VanItallie, M.D., for his mentorship and his tireless efforts in getting information about ketones as an alternative fuel out to the scientific community.
I want to express my deepest appreciation to our helpers, who have made it possible for us to provide Steve with assisted living at home for nearly three years now, surrounded by people who truly love and care for him, our daughter Joanna Newport, her husband Forrest Rand, and other caregivers Sybil Kennedy, Joseph Brust, and Nemuel Major. Without them, taking care of Steve at home would be truly impossible. I also wish to thank Joanna for her graphic designs and her help with keeping up my website and Facebook pages. I also want to recognize the love and support of our daughter Julie DiPalo, and our many other family members and friends.
I wish to express my love and deepest appreciation to my sister Angela Bertke for always being there for me and for her never-ending moral support. I also want to thank her for the many hours spent critiquing and proofreading this book, as well as getting the message out to others. I want to thank her husband John Bertke, my brother-in-law, for caring and being right there behind her.
I want to recognize Dominic D Agostino, Ph.D., at the University of South Florida, for his friendship, moral support, and dedication to researching how ketones might benefit children and adults suffering from epilepsy, cancer, and neurodegenerative diseases, and for otherwise spreading the gospel of ketones. I also wish to thank David Morgan, Ph.D., of the Byrd Alzheimer s Institute at the University of South Florida for recognizing the potential of ketones as a treatment and for conducting the first pilot study of coconut oil in people with Alzheimer s that I am aware of.
I want to acknowledge the publisher Norman Goldfind for putting this message into print, editor Cheryl Hirsch for her expertise and guidance, and publicist Courtney Dunham for her great help in bringing this message to the public.
Most important, I want to thank my husband, Steve, for more than forty years of love, support, and patience and for being the kind of person you want to fight for.
Preface
One sometimes finds what one is not looking for.
-S IR A LEXANDER F LEMING , S COTTISH BIOLOGIST AND DISCOVERER OF PENICILLIN IN 1928
One chief complaint in the reviews of my first book, Alzheimer s Disease: What If There Was a Cure? The Story of Ketones , from researchers and physicians, including those from the Alzheimer s Association, is that the idea of using ketones as an alternative fuel to treat Alzheimer s disease hasn t had large clinical trials to back it up. While I agree that such studies are needed, how will they ever take place without awareness of the idea in the first place? Bringing awareness of ketones as an alternative fuel for the brain as a potential treatment for Alzheimer s and other neurodegenerative diseases was, and still is, my primary objective in writing these books.
Nearly seven years after I began trying to get this message out in June 2008, funding is still needed for the mass production and clinical testing of the ketone ester (a concentrated form of ketones) developed by Dr. Richard Veech, a senior scientist at the National Institutes of Health. The first clinical trial of a coconut oil and medium-chain triglyceride (MCT) oil combination for Alzheimer s disease is finally underway. My earliest messages, beginning just two weeks after Steve began to show dramatic improvement, were to scientists and politicians, asking them to look closely at the scientific rationale for providing ketones to the insulin-resistant brain and to study this urgently. (In Alzheimer s, insulin resistance prevents the brain cells from accepting glucose, their primary fuel.) It is as if the expectation, by even physicians who should know better, is that somehow such large-scale studies will magically materialize overnight or that someone would have thought of it a long time ago if there was any merit to it. They expect their patients, who will likely die or seriously worsen while waiting, to hold off on trying this dietary intervention until the results of clinical trials are in, even though the scientific basis justifies an individual trial on a What-do-you-have-to-lose? basis. Since coconut oil is a food, a staple in the diets of millions in other parts of the world, why can t a person serve as their own control (comparison subject) in a situation where the only other currently available alternative is continued worsening and death?
If the medical establishment had summarily dismissed important discoveries in the early part of the last century due to the expectation of having large, randomized, double-blind clinical trials before treatments were approved for general use, people might still be dying on a large-scale basis from bacterial infections. Likewise would type 1 and many type 2 diabetics have died from lack of insulin to control their blood sugar (glucose). The randomized double-blind clinical trial, now considered the gold standard, was not recognized as such until the latter part of the twentieth century. These trials are used to help determine if a drug or medical device produces the desired effect in a real-world situation and whether there are adverse effects. No doubt they play a critical role in determining which drugs might be suitable for use to treat disease, however, they are not infallible.